Alerts will be sent to your verified email
Verify Email
VALIANTLAB
|
Valiant Laboratories
|
iStreet Network
|
Kappac Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
9.66 % | 5.48 % | -0.23 % |
|
5yr average Equity Multiplier
|
1.76 | -1.13 | 1.04 |
|
5yr Average Asset Turnover Ratio
|
0.81 | 0.21 | 0.0 |
|
5yr Avg Net Profit Margin
|
2.4 % | 1.44 % | 0.0 |
|
Price to Book
|
1.16 | 7.46 | 9.43 |
|
P/E
|
0.0 | 68.97 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
75.62 Days | 22.21 Days | 0.0 |
|
Inventory Days
|
18.84 Days | 0.0 | 0.0 |
|
Days Receivable
|
161.25 Days | 220.87 Days | 0.0 |
|
Days Payable
|
82.33 Days | 39.73 Days | 0.0 |
|
5yr Average Interest Coverage Ratio
|
44.93 | -107.0 | -2260.1 |
|
5yr Avg ROCE
|
7.68 % | -79.54 % | -0.23 % |
|
5yr Avg Operating Profit Margin
|
0.79 % | 1.54 % | 0.0 |
|
5 yr average Debt to Equity
|
0.48 | -1.09 | 0.03 |
|
5yr CAGR Net Profit
|
n/a | n/a | 51.57 % |
|
5yr Average Return on Assets
|
4.39 % | -113.8 % | -0.22 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
74.94 % | 19.33 % | 0.0 |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -26.87 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Valiant Laboratories
|
iStreet Network
|
Kappac Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
-
|
|
Asset Break-Up - Geography Wise
|
Asset Break-Up - Geography Wise
|
-
|
-
|